Starfire Investment Advisers’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
BCI
PAM
AWMS
Starfire Investment Advisers's PJP Position: Q2 2020 in Review
Starfire Investment Advisers held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2020 at 12,141 shares worth $785K. The position accounts for 0.37% of the portfolio, ranked #67.
Starfire Investment Advisers first reported a position in PJP in Q1 2015 and has held it in 21 quarters since. The position peaked at $1.53M in Q2 2015. 86 funds tracked by Wall St. Rank hold PJP as of Q2 2020.
- Starfire Investment Advisers held 12,141 shares of Invesco Pharmaceuticals ETF worth $785K as of Q2 2020.
- Starfire Investment Advisers left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2020.
- Invesco Pharmaceuticals ETF made up 0.37% of Starfire Investment Advisers's portfolio in Q2 2020, its #67 holding.
- Starfire Investment Advisers first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and has held it in 21 quarters since.
- Starfire Investment Advisers's Invesco Pharmaceuticals ETF position peaked at $1.53M in Q2 2015.
- 86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2020.
Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.